| Literature DB >> 19781696 |
Miranda Harris-Glocker1, Kristin Davidson, Lynda Kochman, David Guzick, Kathleen Hoeger.
Abstract
We studied the effect of metformin or placebo in a lifestyle modification program combined with oral contraceptives (OC) on quality-of-life parameters measured by the polycystic ovary syndrome (PCOS) questionnaire in obese adolescent women with validated PCOS. The quality-of-life indicators were measured at baseline and conclusion for five domains on the PCOS questionnaire, with equal improvement in scores in both placebo and metformin groups, suggesting that the addition of metformin does not add improvement to quality-of-life measures above those observed with lifestyle modification and OC treatment. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19781696 PMCID: PMC3756311 DOI: 10.1016/j.fertnstert.2009.08.006
Source DB: PubMed Journal: Fertil Steril ISSN: 0015-0282 Impact factor: 7.329